Issued Patents 2021
Showing 1–8 of 8 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11111253 | 6-aryl-7-substituted-3-(1H-pyrazol-5-yl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazines as inhibitors of the STAT3 pathway with anti-proliferative activity | Donna M. Huryn, Jennifer Rubin Grandis, Matthew G. LaPorte, Paul A. Johnston, Mark E. Schurdak +1 more | 2021-09-07 |
| 11090389 | Mitochondrially targeted PARP inhibitor, and uses thereof | Hulya Bayir, Robert Clark, Tanja Krainz | 2021-08-17 |
| 10980806 | Small molecule inhibitors of the nuclear translocation of androgen receptor for the treatment of castration-resistant prostate cancer | James K. Johnson, Erin M. Skoda, Joel B. Nelson, Zhou Wang, Serene Tai +2 more | 2021-04-20 |
| 10968196 | Substituted β-lapachones for treating cancer | Chaemin Lim, Wei Qian, Bennett Van Houten | 2021-04-06 |
| 10933077 | TLR4 inhibitors for the treatment of human infectious and inflammatory disorders | Matthew D. Neal, Chhinder P. Sodhi, David J. Hackam | 2021-03-02 |
| 10906876 | Tetrahydroisoquinolines as selective NADPH oxidase 2 inhibitors | Patrick J. Pagano, Maria E. Cifuentes-Pagano, Erin M. Skoda | 2021-02-02 |
| 10894782 | Modulators of P97 AAA ATPase activity | Donna M. Huryn, Matthew G. LaPorte | 2021-01-19 |
| 10882834 | Compounds for treating prostate cancer | Erin M. Skoda, Zhou Wang | 2021-01-05 |